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Abstract 
Objectives: To develop a new semi-automated method (Sheffield TKV Tool) for measuring 
total kidney volume (TKV) from magnetic resonance images (MRI) in patients with autosomal 
dominant polycystic kidney (ADPKD). 
Methods: TKV was initially measured in 61 patients with ADPKD using the Sheffield TKV 
Tool and its performance compared to manual segmentation and other published methods 
(ellipsoidal, mid-slice, MIROS). It was then validated using an external dataset of 65 MRI 
scans.  
Results: 61 patients (mean age 45±14years, baseline eGFR 76±32ml/min/1.73m2) with 
ADPKD had a wide range of TKV (258-3680ml) measured manually. The Sheffield TKV Tool 
was highly accurate (mean volume error of 0.5±5.3% for right kidney, -0.7±5.5% for left 
kidney), reproducible (intra-operator variability -0.2±1.3% and inter-operator variability of 
1.1±2.9%) and outperformed published methods. It took less than 6 minutes to execute and 
performed consistently in an external MRI dataset with TKV acquired using three different 
scanners and measured using a different segmentation methodology (mean volume error was 
3.45±3.96%, n=65). 
Conclusions: The Sheffield TKV Tool is operator friendly and requires minimal user 
interaction. Its rapidity, accuracy and reproducibility highlights it¶s potential for adoption into 
general use for measuring TKV in ADPKD. 
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Keywords (max 5 keywords) 
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Key points (3 to 5 key points) 
This new semi-automated method (Sheffield TKV Tool) to measure total kidney volume (TKV) 
will facilitate the routine clinical assessment of patients with ADPKD. 
 
Abbreviations and acronyms (Non-commonly used)     
CoV:  Coefficient of Variation 
DSC:  Dice Similarity Coefficient  
HtTKV: Height Adjusted Total Kidney Volume 
LKV:  Left Kidney Volume 
LSM:   Level Set Method 
MIROS: Minimal Interaction Rapid Organ Segmentation  
RKV:  Right Kidney Volume 
TRUFI: True Fast Imaging with Steady-State Free Precession 
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Introduction 
Autosomal dominant polycystic kidney disease (ADPKD) is the commonest inherited kidney 
disease and fourth leading cause of end stage renal failure (ESRF) worldwide [1, 2]. It is 
characterised by the gradual progressive development and growth of renal cysts which result 
in increased total kidney volume (TKV).  
Changes in estimated glomerular filtration rate (eGFR) are conventionally used to measure loss 
of kidney function. In ADPKD however, eGFR does not change until the later stages of disease 
due to compensatory glomerular hyperfiltration [3] thus limiting its use to late disease [4]. In 
the earlier stages of disease, increases in TKV are detectable before decreases in eGFR [5]. A 
single baseline TKV measurement in combination with age and eGFR (Mayo Imaging 
Classification) has also been shown to accurately predict future decline in kidney function [6]. 
TKV has been approved by both the US Food and Drug Administration (FDA) and the 
European Medicines Agency (EMA) as a prognostic biomarker for disease progression in 
ADPKD to facilitate the enrichment of patients at higher risk of rapid progression in future 
clinical trials [4]. In addition, Tolvaptan [7] has been approved for use in ADPKD patients in 
Europe with evidence of rapid disease progression. Guidance from the ERA-EDTA 
recommends the use of TKV to select higher risk patients for treatment [8]. 
The current gold standard method for measuring TKV from MRI involves manual tracing of 
the kidney boundary on each MRI slice using dedicated software and summing the product of 
area measurements and slice thickness [9]. This is time consuming and subject to intra- and 
inter-operator variability errors.  There is a clear need to develop more rapid and accurate 
methods for measuring TKV to facilitate its wider adoption into clinical use. 
Several semi-automated methods and estimating equations have been developed to address the 
challenge of measuring TKV in ADPKD [10] (summarised in Supp Table 1). Fully automatic 
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methods to estimate TKV have also been reported [11-13] although they require a good training 
dataset to include severely cystic kidneys due to the associated geometric and anatomical 
variability.  
In this paper, we describe the development and validation of a new, rapid, high performance 
semi-automated method (Sheffield TKV Tool) for measuring TKV in a representative group of 
patients with ADPKD and a wide range of TKV.  
 
Materials and Methods  
Study population 
Sixty-one patients with ADPKD and stage 1-3 chronic kidney disease (CKD) attending a 
specialist PKD clinic at Sheffield Kidney Institute consented to an unenhanced abdominal MRI 
for measurement of TKV. Renal function (eGFR [14]) was measured at baseline (within one 
month of the MRI) and the most recent follow up result was recorded (2.00±0.52 years; 0.07-
2.72 years). The study was approved by a research ethics committee (13/YH/026). 
 
MRI Acquisition 
Kidney MRI scans were coronal true fast imaging with steady-state free precession (TRUFI) 
T2-weighted sequences (Siemens Avanto 1.5T scanner) with the following parameters: 4mm 
slice thickness, 0mm slice gap, 2ms echo time, 3.99ms repetition time, 60o flip angle, 
0.68x0.68mm in plane resolution and 512x512 acquisition matrix. 
 
Sheffield TKV Tool Development  
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The Sheffield TKV Tool was implemented using a MATLAB 2016b (MathWorks, Natick, MA) 
framework. The right or left kidney was segmented individually from coronal MRI slices using 
image processing techniques (Figure 1). Coronal kidney region slices were selected using mid-
sagittal plane (Figure 1: Step 2). Prior to segmentation pre-processing steps were applied to 
reduce motion artefact, intra- and inter- slice intensity variations [15] from the selected coronal 
slices (Figure 1: Step 3). On the cropped region of interest (Figure 1: Step 4), the user defined 
contour (Figure 1: Step 5) was propagated using hybrid level set method (LSM) [16] that utilize 
edge (gradient) as well as regional statistics to obtain final segmentation boundary. The energy 
function  used in hybrid LSM [16] is given as:  
 
where  is the level set function.  is the image to be segmented,  is smooth Heaviside 
function which considers area around contour, g is image edge (boundary) map where contour 
should be attracted and is set to be  with c controlling the slope.  is the image 
domain and and are predefined weights to balance two terms. The first term on the right 
hand side of equation defines that region to be segmented should have intensity greater than  
which is set to 50. Parameters  and  are set to 0.01 and 100 respectively. Evolving contour 
(level set function) is stopped after 100 iterations to obtain expected kidney region outline 
(Figure 1: Step 6). These parameters were determined experimentally from a random dataset 
of 10. The final contour obtained is not highly sensitive to the choice of parameters. After 
segmentation, kidney volume (KV) was calculated by summing the product of areas of the 
kidney region and slice thickness. The Sheffield TKV Tool was applied separately for right (R) 
and left (L) kidneys to enable errors specific to either side to be identified quickly. The tool 
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was developed and optimised using 10 random cases from the patient cohort (training set) and 
internally validated on the remaining (51) patients images.  
 
TKV measurements  
To obtain reference TKV measurements, the gold standard method of manual segmentation 
was performed using MIM Maestro (Cleveland, OH, USA) on T2 TRUFI coronal MR images 
of all 61 patients by an experienced image analyst (PM). PM was blinded to the development 
and TKV measurements of Sheffield TKV Tool. Consistent with standard methods of 
manually measuring TKV [9, 15], blood vessels in the kidney and hilum (structures including 
ureter, blood vessels and nerves entering each kidney) were excluded [17]. A second image 
analyst (TD) used the Sheffield TKV Tool (TD1) to measure the right (R) and left (L) kidney 
volumes (KV) separately and compared its performance to that of the mid-slice method [6, 
18] and MIROS tool [15] in all 61 patients and used the ellipsoid formula on 51 (typical, 
class 1) patients. TKV was obtained by summing right and left KV. To apply the MIROS 
tool, open source code was obtained from https://gitlab.com/Philbrick/rilcontour 
and re-written in MATLAB.  The MIROS tool was developed for HASTE sequences. To 
enable use on TRUFI sequence, parameters were optimised using 10 random representative 
cases from the patient cohort (training set) and validated on the remaining (51) patients images.  
To assess the inter-operator variability (PM and TD) of manual segmentation, TD manually 
(TDm1) measured TKV for 40 kidneys from a representative sub-set of 20 patients (TKV 258-
3680 ml). TD repeated the manual segmentation on the same dataset after one month (TDm2) 
to assess the intra-operator variability.  
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To assess the inter-operator variability of the Sheffield TKV Tool, image analyst PM calculated 
TKV for a similar dataset of 20 patients (PMs). The intra-operator variability of the Sheffield 
TKV Tool was assessed by TD on two occasions (TD1, TD2) separated by one month. 
 
Mayo risk classification 
We classified patients in the development cohort into Class 1 (typical) or Class 2 (atypical) 
based on their kidney morphology on MRI as defined in the Mayo Imaging classification ([6]). 
Class 1 patients were further subdivided into categories 1A-1E, which has been shown to 
correlate with the rate of disease progression measured by eGFR change ([6]). 
 
Validation of Sheffield TKV Tool 
TRUFI MRI renal images of 65 ADPKD patients who participated in the DIPAK-1 study were 
acquired using one of three scanners (GE Medical Systems (16), Siemens (37) and Philips 
Healthcare (12)). De-identified DICOM image data from the DIPAK-1 study was transferred 
to Groningen Medical Centre and converted to the NIFTI file format by the dcm2nii software. 
The images had a reconstructed matrix size of at least 256 × 256 × Z (with Z large enough to 
cover the full extent of the kidneys within the imaged volume). Image voxel sizes were most 
commonly on the order of 1.5 mm in-plane with 4 mm slice thickness and spacing between 
slices. The Medical Ethics Committee of University Medical Center Groningen approved the 
trial protocol that was conducted in accordance with the International Conference of 
Harmonization Good Clinical Practice Guidelines and in adherence to the ethics principles that 
have their origin in the Declaration of Helsinki. All patients gave written informed consent. 
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Kidney boundaries were manually traced using commercially available software Analyze 
Direct 11.0 (Analyze Direct, Inc., Overland Park, KS, USA) and kidney volumes were 
calculated from the set of contiguous images by summing the products of the area 
measurements within the kidney boundaries and slice thickness. Non-renal parenchyma, e.g. 
the renal hilum was excluded from measurement. Importantly, all measurements were 
performed by readers blinded for patient number and previous TKV measurements [9]. 
Separate KV for left and right kidneys was determined using MATLAB software to separate 
the measured TKV. The Sheffield TKV Tool was used (TD) to measure KV on this dataset in a 
blinded manner and its performance relative to the reference manual segmentation values was 
then assessed.  
 
Statistical Analyses 
Baseline demographics are reported as mean ± standard deviation (SD). Agreement was 
assessed using Bland-Altman (BA) analyses to determine the mean difference between TKV 
for the various methods. Both actual and percentage (%) difference in volume were evaluated. 
For development of the Sheffield TKV Tool, sample size was calculated for BA agreement 
assessment [19] using the level of significance (Type I error), a power value (Type II error), 
expected mean, SD and maximum acceptable percentage (%) volume difference between 
reference and TKV Tool measurements [19]. Based on published literature [11, 15], the 
expected mean (bias in BA plot) was 2%, the expected SD (precision in BA plot) 5% and the 
maximum allowed difference 15% (greater than mean+2*SD) [19]. Thus, for of 0.05, a 
power of 0.80, the minimum required number of TKV measurement pairs was 60. Bias (mean) 
obtained from different methods was assessed using paired sample t-test.  
U
U
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Spatial overlap between segmentation outlines was determined using the dice similarity 
coefficient (DSC) [20]. A DSC value of 1 implies complete overlap while a value of 0 implies 
no overlap. Inter- and intra-operator variability was also assessed by coefficient of variation 
(CoV) [21]. 
 
Results  
Characteristics of the development cohort 
61 ADPKD patients (32 female, 29 male) with a mean age of 45±14 (20-77) years and eGFR 
of 76±32 ml/min/1.73m2 (33-175 ml/min/1.73m2) participated in this study. They represented 
a wide spectrum of disease with gold standard TKV ranging (mean±SD) between 258-3680 ml 
(1167±798 ml). Their kidneys had variable morphology (shape, size and heterogeneous cysts) 
(Figure 2) and 42 (69%) patients had liver cysts. Based on the Mayo imaging classification [6], 
51 patients were categorised as Class 1 (typical) and 10 patients as Class 2 (atypical disease). 
Class 1 patients were further sub-divided into five prognostic groups (1A-1E) [6].  
 
Performance of the Sheffield TKV Tool 
Table 1 summarises the performance of the Sheffield TKV Tool, the ellipsoid, mid-slice and 
MIROS methods compared to the reference gold standard manual method in all 61 patients 
(122 kidneys). The mean TKV of 1153±786 ml (258-3737 ml), measured by the Sheffield TKV 
Tool, was close to manually measured TKV (1167±798 ml; 258-3680 ml), whereas the 
ellipsoid (1238±742 ml; 261-3437 ml), mid-slice (1196±827 ml; 276-4082 ml) and MIROS 
(1182±821 ml; 261-3780 ml) methods overestimated TKV.  
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In terms of volume error (Table 1, Figure 3), the Sheffield TKV Tool performed more accurately 
and with greater precision with a mean TKV difference of -0.3±3.8% compared to the ellipsoid 
(3.1±14.1%), mid-slice (3.8±9.2%) and MIROS (1.4±5.1%) methods. Paired sample t-test 
demonstrated that there was no statistically significant difference ( (2-tailed) = 0.008) 
between bias obtained using the Sheffield TKV Tool and MIROS method. The Sheffield TKV 
Tool demonstrated no particular bias and had a narrower 95% confidence interval. 
In contrast, the estimating equations were less reliable with a positive bias (overestimation of 
TKV) and more variable results (wider 95% confidence intervals).  
 
Figure S1 shows the high agreement (0.89±0.06 (R KV) and 0.90±0.04 (L KV) of the DSC for 
the Sheffield TKV Tool compared to the manual method. There was high inter- (-0.5±3.5%, 
CoV: 2.3) and intra- (0.5±2.2%, CoV: 1.6) operator reproducibility for manual TKV 
measurements. Inter- (1.1±2.9%, CoV: 2.2) and intra- (-0.2±1.3%, CoV: 0.8) operator 
reproducibility for the Sheffield TKV Tool was higher than for manual measurements (Table 
2). 
 
Validation of the Sheffield TKV Tool in an external dataset 
The MRI of 65 patients (25 female, 40 male) with ADPKD, mean age 50±8 (26-61) years and 
eGFR of 52±13 (33-78) ml/min/1.73m2 with a representative spectrum of disease with gold 
standard TKV ranging (mean±SD) between 400-7431 ml (2408±1806 ml) were used. These 
patients also had more severe associated polycystic liver disease. Table 3 summarises the 
performance of the Sheffield TKV Tool compared to the reference gold standard manual method 
(Analyze Direct) in all 65 patients (130 kidneys). The mean TKV of 2344±1806 ml, measured 
by the Sheffield TKV Tool, was close to the manually measured TKV (2408±1806 ml).  
 
U
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The mean volume error (Table 3, Figure 4c) between the Sheffield TKV Tool and the manual 
reference for the external dataset was 3.45±3.96%. This overall positive mean (bias) difference 
indicates the manual volume was greater than the value obtained by the tool. This was attributed 
to the method of manual segmentation, which leaves a slight border around the kidney. 
However, standard deviation (precision) values were comparable to the initial results obtained 
during development of the tool (Table 1). The higher mean volume error for right KV is likely 
to be secondary to the low contrast between the right kidney and liver, which was often very 
cystic. 
 
Time taken to measure TKV  
The average time taken to measure TKV by manual segmentation was 44±18 minutes. In 
comparison, the Sheffield TKV Tool took 5.6±1.5 minutes on the Sheffield cohort and 5±3 
minutes on the external validation cohort. The mean time to perform ellipsoid, mid-slice and 
MIROS methods was 4.5±0.6, 3.2±0.8 and 6.5±2.2 min respectively.  
 
Table 4 shows the number of misclassified patients assigned to Mayo imaging classes (1A-1E) 
based on TKV calculated using various methods (Manual, Ellipsoid, Mid-slice, MIROS and 
Sheffield TKV Tool). Compared to the manual method, the Sheffield TKV Tool misclassified 2 
patients from Class 1C to 1B and 1 patient from Class1A to 1B. However, these two patients 
were misassigned from Class 1C to 1B and Class 1A to 1B by all four methods: in this case, 
the value for manual HtTKV was borderline between Class 1B and 1C (age: 51 years, HtTKV: 
678 ml) or between Class 1B and 1A (age: 36 years, HtTKV: 256 ml) (please refer [6] Supp 
Table S2). In the third patient, the Sheffield TKV Tool significantly under-segmented the kidney 
region due to the presence of large cysts, a current limitation (see later). Overall, class 
assignment based on the Sheffield TKV Tool was comparable to the Mid-Slice and MIROS 
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methods and performed better than the Ellipsoid method which misclassified 8 patients in total, 
6 between Classes 1B and 1C (Table 4).  
  
Discussion  
We report a new semi-automated method (Sheffield TKV Tool) to measure TKV from MRI in 
ADPKD. The tool requires minimal user interaction to define a kidney outline from a coronal 
slice. Compared to manual segmentation, it performed with high accuracy in an unselected 
group of patients with a wide spectrum of disease represented by kidneys with highly variable 
morphology, cyst burden, intensity distribution and extensive range of TKV (range 258-
7431ml). Importantly, it performed with high precision with no bias in measurements of right 
or left kidneys, high agreement (mean DSC: 0.90±0.05, TKV difference: -0.3±3.8%) and 
reproducibility (1.1±2.9%) compared to the manual method. Validation in a representative 
external group of 65 patients with ADPKD confirmed good performance (mean volume error 
3.45±3.96%) with the positive bias caused by the method of manual segmentation which 
includes a slight border around the kidney. 
 
A direct comparison between the Sheffield TKV Tool and two estimation methods (ellipsoid 
and mid-slice) in the same patients showed that it was more accurate and precise than either. 
Unlike the estimation methods, it also clearly outlined the kidney boundaries: these could be 
used as a precursor for the segmentation of renal cysts [22]. The Sheffield TKV Tool also 
performed as well as the MIROS method in terms of precision and accuracy (Table 1). MIROS 
requires more manual interaction for larger kidneys and will therefore likely require more time 
since the user must draw a polygon in-between slices to initiate kidney segmentation unlike the 
Sheffield TKV Tool where manual interaction is independent of kidney size. 
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The Sheffield TKV Tool also performed better (TKV difference: -0.3±3.8%) when compared to 
other published methods [11, 23] (Table S1). Turco et al. [23] reported a greater volume 
difference (-1.3±3.9%) in 30 patients with a TKV range of 693-2029 ml. Kim et al. reported a 
volume error of 4.2±16.8% in 30 patients for training and 30 for validation and a volume range 
of 177-2634 ml with their automatic method [11]. Although no manual interaction is required 
when measuring TKV with this technique, large volume errors  in 4 patients) resulted in 
the subsequent need for manual verification after segmentation.  
 
In terms of efficiency, the reduced time required for the Sheffield TKV Tool would enable 8-10 
TKV measurements to be performed in the time taken for a single manual TKV measurement. 
It performed particularly well on larger kidneys and in a wider range of kidney volumes (258-
7431ml) than previously reported (largest 2837ml) [15, 23]. 
 
Liver cysts can cause considerable challenges when measuring TKV because of the close 
proximity of the liver with the right kidney and less often the left kidney (with much enlarged 
polycystic livers), since the distribution of cysts between the two neighbouring organs can be 
indistinguishable. However in most cases, the Sheffield TKV Tool was able to distinguish 
between liver and kidney cysts even when the visual boundaries appeared vague. There was no 
influence of imaging classification on the performance of the Sheffield TKV Tool: it performed 
equally well in Class 1 and Class 2 patients. This is a considerable advantage since no patients 
requiring TKV measurements need to be excluded. 
 
The current limitations of the Sheffield TKV Tool are a slight under-segmentation and 
measurement of TKV in kidneys associated with exophytic cysts or over-segmentation 
associated with large blood vessels especially when the kidney regions are small (Figure S1j). 
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It has not yet been tested for serial measurments of TKV measurements to monitor natural 
history or response to treatment. A future goal is therefore to apply image registration 
techniques for this purpose [24]. Finally, the misclassification of 2 patients to a lower risk class 
(1C to 1B) based on TKV suggests that in cases with borderline TKV values between classes 
or with atypical outlines leading to under-segmentation, manual reanalysis may be required 
[6]. 
 
In summary, the accuracy, reproducibility and rapidity of the Sheffield TKV Tool highlights its 
potential for wider adoption to measure TKV as a prognostic marker routinely in patients with 
ADPKD.  
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Table 1:  Accuracy and precision of different semi-automated methods of measuring or estimating KV compared to manual segmentation.  
Table 2:  Intra- and inter-operator variability to assess reproducibility and precision of the Sheffield TKV Tool. 
Table 3: Validation: Accuracy and precision of Sheffield TKV Tool compared to manual segmentation in an external dataset. 
Table 4: Number of Class1 (A-E) ADPKD (out of 51) patients [6] misclassified based on TKV measured using various TKV measurement tools. 
Assignment by manual TKV measurements was used as reference. 
 
 
 
 
 
 
  
20 
 
Figure Legends  
Figure 1: Flow chart of Sheffield TKV Tool. 1. The tool initially loads DICOM (T2 TRUFI) series. 2. The user selects the approximate sagittal 
mid-slice and identifies two points to define the kidney edge which allows selection of coronal slices that contain the kidney. 3. The selected 
slices are pre-processed to remove motion artefact, intra- and inter- slice intensity variations. Step 3 shows MRI slices before and after pre-
processing respectively. 4. The user previews the cropped image to check the entire kidney is included within the defined region and 5. Level set 
method is manually initialised near the kidney region boundary (white outline) only on the mid-coronal slice, 6. The final kidney region outline 
(white outline) is obtained based on a hybrid level set method.  
Figure 2: Representative ADPKD kidney MR images used to test Sheffield TKV Tool 
Figure 3: Bland±Altman analysis of different methods (Ellipsoid, Mid-Slice, MIROS and Sheffield TKV Tool) to measure TKV compared 
to the reference manual method. Bland-Altman plots (bold line = mean; dashed lines = 95% confidence intervals) comparing the percentage 
(%) volume difference of each method to the reference manual method to measure TKV in 61 patients. The Sheffield TKV Tool demonstrates 
higher accuracy and precision compared to all other methods.  
Figure 4: Bland±Altman analysis of Sheffield TKV Tool to measure TKV compared to the reference manual method for external (Groningen) 
dataset.  
a. Right kidney volume b. Left kidney volume c. Total kidney volume. Bland-Altman plots (bold line = mean; dashed lines = 95% confidence intervals) 
comparing the percentage (%) volume difference of tool to the reference manual method to measure TKV in 65 patients. 
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Table 1:  Accuracy and precision of different semi-automated methods of measuring or estimating KV compared to manual 
segmentation.  
 volume (ml) 
 (mean ± SD) 
% volume difference 
(mean ± SD) 
Raw volume difference 
(mean ± SD) 
 
 
Right -KV 
Manual (Reference) 563 ± 400 - - 
Ellipsoid method* 568 ± 394 4.5 ± 19.7 11.0 ± 129.4 
Mid-slice method 568 ± 405 1.9 ± 11.1 4.1 ± 72.6 
Sheffield TKV Tool 561 ± 392 0.5 ± 5.3 -2.8 ± 25.3 
 
 
Left -KV 
Manual (Reference) 597 ± 417 - - 
Ellipsoid method* 576 ± 378 1.7 ± 17.6 -21.9 ± 162.9 
Mid-slice method 629 ± 452 6.1 ± 12.4 31.8 ± 79.0 
Sheffield TKV Tool 592 ± 419 -0.7 ± 5.5 -5.1 ± 29.7 
 
TKV 
Manual (Reference) 1167 ± 798 - - 
Ellipsoid method* 1238 ± 742 3.1 ± 14.1 -10.6 ± 223.76 
Mid-slice method 1196 ± 827 3.8 ± 9.2 35.9 ± 104.9 
MIROS Tool 1182 ± 821 1.4 ± 5.1 21.7 ± 60.8 
Sheffield TKV Tool 1153 ± 786 -0.3 ± 3.8  -7.9 ± 41.8  
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Results are shown for all 61 patients (122 kidneys). Negative values indicate under-estimation of KV compared to manual segmentation. Various 
methods were tested on images of kidneys with manual volumes (analyst A) as reference. The Sheffield TKV Tool was more accurate and precise 
compared to the other methods with no bias for either left or right kidneys.  
SD = standard deviation; KV = kidney volume; TKV = total kidney volume. 
*Results for Ellipsoid method is shown only for Class1 (typical) patients (51 patients). 
For MIROS, no separate volumes were obtained for left and left kidneys, thus results are reported for total kidney volume (TKV).  
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Table 2:  Intra- and inter-operator variability to assess reproducibility and precision of the Sheffield TKV Tool. 
 Comparison % volume 
difference 
(mean ± SD) 
Raw volume 
difference 
(ml) (mean ± SD) 
CoV  
(Coefficient of 
Variation) (%) 
 
 
Right KV 
 
Manual segmentation 
Intra-operator (Bmanual1 vs. 
Bmanual2) 
1.1 ± 2.6 5.4 ± 10.6 1.9 
Inter-operator (Amanual vs. 
Bmanual1) 
0.9 ± 3.4 7.5 ± 12.5 2.4 
 
Sheffield TKV Tool 
Intra-operator (BSheffieldTKVTool1 
vs. BSheffieldTKVTool2) 
-0.1 ± 1.3 1.3 ± 4.2 1.0 
Inter-operator (ASheffieldTKVTool vs.  
BSheffieldTKVTool1) 
1.5 ± 4.6 3.5 ± 22.1  3.4 
 
 
Left KV 
 
Manual segmentation 
Intra-operator (Bmanual1 vs. 
Bmanual2) 
0.1 ± 2.2 1.0 ± 11.0  1.5 
Inter-operator (Amanual vs. 
Bmanual1) 
0.2 ± 3.6 0.4 ± 14.7 2.5 
 
Sheffield TKV Tool 
Intra-operator (BSheffieldTKVTool1 
vs. BSheffieldTKVTool2 ) 
-0.3 ± 1.3 -1.0 ± 6.9 0.9 
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Inter-operator (ASheffieldTKVTool vs. 
BSheffieldTKVTool1) 
1.0 ± 3.1 7.4 ± 17.6 2.3 
 
Results obtained from a subset of 20 patients (40 kidneys). KV= kidney volume; SD = standard deviation. 
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Table 3: Validation: Accuracy and precision of Sheffield TKV Tool compared to manual segmentation using external dataset 
 volume (ml) 
 (mean ± SD) 
% volume difference 
(mean ± SD) 
Raw volume difference 
(mean ± SD) 
 
Right -KV 
Manual (Reference) 1149±871 - - 
Sheffield TKV Tool 1109±862 3.91±5.24 40.35±60.38 
 
Left -KV 
Manual (Reference) 1259±966 - - 
Sheffield TKV Tool 1235±981 3.14±4.95 23.46±99.42 
 
TKV 
Manual (Reference) 2408±1806 - - 
Sheffield TKV Tool 2344±1806 3.45±3.96 63.81±142.81 
 
The reference TKV was provided by manual TKV measurements at University of Groningen using Analyze Direct 11.0 software (Spithoven Est 
TKV AJKD 2015). SD = standard deviation; KV = kidney volume; TKV = total kidney volume. 
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Table 4:  Number of Class1 (A-E) ADPKD (out of 51) patients [6] misclassified based on TKV measured using various TKV measurement 
tools. Assignment by manual TKV measurements was used as reference. 
 
 
 
 
 
  
TKV measurements 
methods 
Class 1 misclassification 
A to B B to A B to C C to B C to D Total 
Ellipsoid method 1 0 3 3 1 8 
Mid-slice method 1 0 0 1 1 3 
MIROS tool 1 1 0 1 0 3 
Sheffield TKV Tool 1 0 0 2 0 3 
Figure 1
Figure 2
Figure 3
Figure 4
Figure S1
Figure S2
